Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-29

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' supplemental application for a generic fixed-dose combination of telmisartan and hydrochlorothiazide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

SUPPL AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)